Cardinal Health, Inc. (CAH): Price and Financial Metrics

Cardinal Health, Inc. (CAH): $62.75

0.98 (+1.59%)

POWR Rating

Component Grades














  • CAH scores best on the Growth dimension, with a Growth rank ahead of 97.37% of US stocks.
  • The strongest trend for CAH is in Value, which has been heading up over the past 179 days.
  • CAH's current lowest rank is in the Sentiment metric (where it is better than 33% of US stocks).

CAH Stock Summary

  • Cardinal Health Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.79% of US listed stocks.
  • CAH's price/sales ratio is 0.09; that's higher than the P/S ratio of merely 0.88% of US stocks.
  • CAH's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 98.75% of US stocks.
  • Stocks that are quantitatively similar to CAH, based on their financial statements, market capitalization, and price volatility, are CROX, ALJJ, CCLP, POLY, and CAPL.
  • Visit CAH's SEC page to see the company's official filings. To visit the company's web site, go to

CAH Valuation Summary

  • CAH's EV/EBIT ratio is 36; this is 22.87% higher than that of the median Healthcare stock.
  • Over the past 243 months, CAH's price/sales ratio has gone down 0.6.
  • CAH's price/sales ratio has moved down 0.6 over the prior 243 months.

Below are key valuation metrics over time for CAH.

Stock Date P/S P/B P/E EV/EBIT
CAH 2021-08-31 0.1 8.5 25.0 36.0
CAH 2021-08-30 0.1 8.4 24.5 35.4
CAH 2021-08-27 0.1 8.4 24.6 35.6
CAH 2021-08-26 0.1 8.3 24.4 35.3
CAH 2021-08-25 0.1 8.4 24.6 35.6
CAH 2021-08-24 0.1 8.4 24.6 35.6

CAH Growth Metrics

    The year over year net income to common stockholders growth rate now stands at 127.68%.
  • The 2 year net cashflow from operations growth rate now stands at -24.23%.
  • Its 3 year cash and equivalents growth rate is now at 32.33%.
CAH's revenue has moved up $16,640,000,000 over the prior 15 months.

The table below shows CAH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 171,286 1,491 555
2021-09-30 167,370 1,513 1,135
2021-06-30 162,467 2,429 611
2021-03-31 156,570 2,004 1,151
2020-12-31 156,452 3,403 1,382
2020-09-30 154,646 2,883 973

CAH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CAH has a Quality Grade of C, ranking ahead of 64.17% of graded US stocks.
  • CAH's asset turnover comes in at 3.718 -- ranking 10th of 105 Wholesale stocks.
  • AMRK, MCK, and PETQ are the stocks whose asset turnover ratios are most correlated with CAH.

The table below shows CAH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 3.718 0.042 0.047
2021-03-31 3.661 0.044 0.112
2020-12-31 3.717 0.045 0.121
2020-09-30 3.756 0.045 0.109
2020-06-30 3.773 0.045 -0.332
2020-03-31 3.784 0.045 -0.379

CAH Price Target

For more insight on analysts targets of CAH, see our CAH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $57.92 Average Broker Recommendation 1.93 (Hold)

CAH Stock Price Chart Interactive Chart >

Price chart for CAH

CAH Price/Volume Stats

Current price $62.75 52-week high $64.53
Prev. close $61.77 52-week low $45.85
Day low $61.90 Volume 2,954,100
Day high $62.76 Avg. volume 2,701,664
50-day MA $55.18 Dividend yield 3.21%
200-day MA $53.97 Market Cap 17.09B

Cardinal Health, Inc. (CAH) Company Bio

Cardinal Health provides pharmaceutical and medical products and services that help pharmacies, hospitals and other healthcare providers focus on patient care. The company was founded in 1979 and is based in Dublin, Ohio.

CAH Latest News Stream

Event/Time News Detail
Loading, please wait...

CAH Latest Social Stream

Loading social stream, please wait...

View Full CAH Social Stream

Latest CAH News From Around the Web

Below are the latest news stories about Cardinal Health Inc that investors may wish to consider to help them evaluate CAH as an investment opportunity.

$26 billion opioid crisis settlement finalized with Johnson & Johnson, 3 drug distributors

Drug distributors McKesson, AmerisourceBergen and Cardinal Health are part of the settlement.

New York Daily News | February 25, 2022

US Drugmaker, Distributors Finalize $26B Opioid Settlement

Drugmaker Johnson & Johnson and three major distributors finalized nationwide settlements over their role in the opioid addiction crisis Friday, an announcement that clears the way for $26 billion to flow to nearly every state and local government in the U.S. Taken together, the settlements are the largest to date among the many opioid-related cases that have been playing out across the country. They''re expected to provide a significant boost to efforts aimed at reversing the crisis in places that have been devastated by it, including many parts of rural America. Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKesson announced the settlement plan last year, but the deal was contingent on getting participation from a critical mass of state and local governments. Friday was t...

Voice of America News | February 25, 2022

US pharma groups advance $25 billion opioid settlement

The three distributors, McKessen, AmerisourceBergen and Cardinal Health, each "independently determined" that enough states and litigating political subdivisions had signed on to advance the agreement to pay out $19.5 billion over 18 years to thousands of plaintiffs, according to a joint press release from the companies.

Economic Times India | February 25, 2022

Opiate crisis: J&J and 3 distributors agree to pay nearly 25 billion dollars

BET À DAY Drugmaker Johnson & Johnson and three major distributors (McKessen, AmerisourceBergen and Cardinal Health) confirmed on Friday that they will pay $24.5 billion to end more than 3,000 lawsuits by US states and thousands of communities. In a joint statement, the distributors said they had independently determined that there was “sufficient participation from […] The post Opiate crisis: J&J and 3 distributors agree to pay nearly 25 billion dollars first appeared on The Bobr Times .

The Bobr Times | February 25, 2022

Johnson & Johnson Sees A Strong Move: Is It Ready For A Breakout?

Johnson & Johnson (NYSE: JNJ ) shares are trading higher Friday after the company agreed to finalize a proposed $26 billion settlement resolving more than 3,000 lawsuits, mainly by state and local governments, seeking to hold it and three other companies responsible for the opioid abuse crisis. The other companies are distributors McKesson Corp (NYSE: MCK ), AmerisourceBergen Corp (NYSE: ABC ) and Cardinal Health Inc (NYSE: CAH ). Johnson & Johnson was up 4.97% at $166 Friday afternoon at publication. See Also: Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits Johnson & Johnson Daily Chart Analysis The stock recently bounced off support in a sideways channel and has been pushing higher, now nearing the resistance level of the channel. Support was found near … Full story availa...

Benzinga | February 25, 2022

Read More 'CAH' Stories Here

CAH Price Returns

1-mo 18.42%
3-mo 15.20%
6-mo 21.56%
1-year 27.63%
3-year 58.24%
5-year 12.51%
YTD 24.06%
2021 -0.40%
2020 10.09%
2019 18.04%
2018 -24.50%
2017 -12.65%

CAH Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CAH Dividend History

Continue Researching CAH

Want to see what other sources are saying about Cardinal Health Inc's financials and stock price? Try the links below:

Cardinal Health Inc (CAH) Stock Price | Nasdaq
Cardinal Health Inc (CAH) Stock Quote, History and News - Yahoo Finance
Cardinal Health Inc (CAH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4555 seconds.